Areas of
Practice

PATENTS - Patented medicines - Excessive prices

Thursday, September 02, 2021 @ 5:34 AM  

Appeal by Alexion Pharmaceuticals from the dismissal of its application for judicial review of a decision of the Patented Medicine Prices Review Board finding that Alexion priced its drug, Soliris, excessively....